Autopen 24


Combined with:

Lantus

Indications and Reactions:

Role Indications Reactions
Secondary
Type 2 Diabetes Mellitus 26.2%
Device Therapy 14.6%
Type 1 Diabetes Mellitus 11.9%
Blood Pressure 10.8%
Hypertension 7.7%
Cardiac Disorder 3.4%
Thyroid Disorder 2.9%
Diabetes Mellitus 2.7%
Gastric Disorder 2.7%
Anticoagulant Therapy 2.1%
Gastrointestinal Disorder 2.1%
Vitamin Supplementation 1.9%
Depression 1.6%
Hypothyroidism 1.6%
Antidepressant Therapy 1.4%
Cardiovascular Disorder 1.4%
Renal Disorder 1.4%
Thrombosis 1.3%
Diabetic Neuropathy 1.1%
Immunosuppression 1.1%
Hypoglycaemia 11.4%
Hyperglycaemia 8.9%
Weight Increased 7.3%
Syncope 6.5%
Visual Impairment 6.5%
Vomiting 6.5%
Blood Glucose Increased 5.7%
Cerebrovascular Accident 5.7%
Product Quality Issue 4.9%
Weight Decreased 4.9%
Injection Site Pain 4.1%
Pharmaceutical Product Complaint 4.1%
Vision Blurred 4.1%
Pneumonia 3.3%
Urinary Tract Infection 3.3%
Wrong Drug Administered 3.3%
Diabetic Ketoacidosis 2.4%
Dizziness 2.4%
Eye Haemorrhage 2.4%
Fall 2.4%
Concomitant
Type 2 Diabetes Mellitus 25.6%
Device Therapy 22.0%
Blood Pressure 11.6%
Hypertension 6.1%
Gastric Disorder 5.5%
Type 1 Diabetes Mellitus 4.3%
Blood Cholesterol 3.7%
Diabetes Mellitus 3.7%
Cardiac Disorder 2.4%
Renal Disorder 2.4%
Immunosuppressant Drug Therapy 1.8%
Thyroid Disorder 1.8%
Anticoagulant Therapy 1.2%
Cholesterol 1.2%
Diabetic Neuropathy 1.2%
Diuretic Therapy 1.2%
Finger Amputation 1.2%
Hepatitis 1.2%
Rheumatoid Arthritis 1.2%
Antiplatelet Therapy 0.6%
Visual Impairment 18.5%
Blood Glucose Increased 7.4%
Syncope 7.4%
Tremor 7.4%
Blood Pressure Increased 3.7%
Carpal Tunnel Syndrome 3.7%
Device Malfunction 3.7%
Diabetes Mellitus Inadequate Control 3.7%
Drug Administration Error 3.7%
Dyspnoea 3.7%
Glaucoma 3.7%
Glycosylated Haemoglobin Increased 3.7%
Haemodialysis 3.7%
Hepatitis A 3.7%
Hyperglycaemia 3.7%
Hypertension 3.7%
Hyperthyroidism 3.7%
Hypoacusis 3.7%
Hypoaesthesia 3.7%
Knee Deformity 3.7%

Drug Data